{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:36:35Z","timestamp":1787646995087,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012324","name":"University Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jcf.2026.03.024","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:32:48Z","timestamp":1775151168000},"page":"426-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Increased gastrointestinal cancer risk in cystic fibrosis: Screening, prevention, and future directions"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8767-2795","authenticated-orcid":false,"given":"Linda C.","family":"Cummings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2026.03.024_bib0001","unstructured":"Cystic Fibrosis Foundation Patient Registry 2024 Annual Data Report [Internet]. Bethesda, MD; [cited 2026 Jan 1]. Available from: cff.org\/medical-professionals\/patient-registry."},{"issue":"2","key":"10.1016\/j.jcf.2026.03.024_bib0002","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States","volume":"105","author":"Maisonneuve","year":"2013","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.024_bib0003","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1470-2045(18)30188-8","article-title":"Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis","volume":"19","author":"Yamada","year":"2018","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.024_bib0004","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcf.2021.07.004","article-title":"Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study","volume":"21","author":"Archangelidi","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.024_bib0005","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcf.2022.10.001","article-title":"The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: an English population-based study","volume":"22","author":"Birch","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"32","key":"10.1016\/j.jcf.2026.03.024_bib0006","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1038\/onc.2015.483","article-title":"CFTR is a tumor suppressor gene in murine and human intestinal cancer","volume":"35","author":"Than","year":"2016","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.024_bib0007","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.immuni.2017.11.010","article-title":"Cystic fibrosis transmembrane conductance regulator attaches tumor suppressor pten to the membrane and promotes anti pseudomonas aeruginosa immunity","volume":"47","author":"Riquelme","year":"2017","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.024_bib0008","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.1914912117","article-title":"Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions","volume":"117","author":"Miller","year":"2020","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"10.1016\/j.jcf.2026.03.024_bib0009","article-title":"Risk of pancreatic cancer in cystic fibrosis and cystic fibrosis transmembrane conductance regulator germline variants: a retrospective cohort study","volume":"16","author":"Patel","year":"2025","journal-title":"Clin Transl Gastroenterol [Internet]"},{"key":"10.1016\/j.jcf.2026.03.024_bib0010","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1136\/gut.2005.074534","article-title":"Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma","volume":"54","author":"McWilliams","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jcf.2026.03.024_bib0011","doi-asserted-by":"crossref","unstructured":".Wu Hao, Gao Sui-Zhi, Yin Ling-Di, Wang Ya-Hui, Deng Shun-Jiang, Lu Zi-Peng, et al. Germline mutations and pancreatic cancer risk in chronic pancreatitis. Gut 74:1195\u20131196.","DOI":"10.1136\/gutjnl-2024-334277"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.024_bib0012","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12944-024-02025-z","article-title":"Association of saturated fatty acids with cancer risk: a systematic review and meta-analysis","volume":"23","author":"Mei","year":"2024","journal-title":"Lipids Health Dis"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.024_bib0013","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ijc.34544","article-title":"Saturated fatty acid intake, genetic risk and colorectal cancer incidence: A large-scale prospective cohort study","volume":"153","author":"Fan","year":"2023","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.024_bib0014","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13073-020-0710-2","article-title":"Interactions between the gut microbiome and host gene regulation in cystic fibrosis","volume":"12","author":"Dayama","year":"2020","journal-title":"Genome Med"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.024_bib0015","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/j.gastro.2017.12.012","article-title":"Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations","volume":"154","author":"Hadjiliadis","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.024_bib0016","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jcf.2016.01.002","article-title":"Colonoscopic screening shows increased early incidence and progression of adenomas in cystic fibrosis","volume":"15","author":"Niccum","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.024_bib0017","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcf.2025.09.008","article-title":"Stool and symptom testing in ColoREctal evaluation for neoplasia in cystic fibrosis (SCREEN-CF)","volume":"25","author":"Taylor","year":"2026","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.024_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2025-001954","article-title":"Limited utility of faecal immunochemical testing in a colorectal cancer screening programme for adults with cystic fibrosis: insights from a prospective UK study","volume":"12","author":"Azam","year":"2025","journal-title":"BMJ Open Gastroenterol"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.024_bib0019","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcf.2016.07.011","article-title":"Cancer risk among lung transplant recipients with cystic fibrosis","volume":"16","author":"Fink","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"12","key":"10.1016\/j.jcf.2026.03.024_bib0020","first-page":"1445","article-title":"Body mass index and additional risk factors for cancer in adults with cystic fibrosis","volume":"33","author":"Knotts","year":"2022","journal-title":"Cancer Causes Control"},{"issue":"7","key":"10.1016\/j.jcf.2026.03.024_bib0021","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/hmg\/ddaf007","article-title":"Functional variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene are associated with increased risk of colorectal cancer","volume":"34","author":"Prizment","year":"2025","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1016\/j.jcf.2026.03.024_bib0022","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.trecan.2024.07.006","article-title":"Yetkin-Arik B. CFTR and colorectal cancer susceptibility: an urgent need for further studies","volume":"10","author":"Spelier","year":"2024","journal-title":"Trends Cancer"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.024_bib0023","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jcf.2023.10.001","article-title":"Reduction in abdominal symptoms (CFAbd-Score), faecal M2-pyruvate-kinase and calprotectin over one year of treatment with elexacaftor-tezacaftor-ivacaftor in people with CF aged \u226512 years \u2013 the RECOVER study","volume":"23","author":"Mainz","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.024_bib0024","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jcf.2025.05.006","article-title":"Fecal microbiota changes in people with cystic fibrosis after 6 months of elexacaftor\/tezacaftor\/ivacaftor: findings from the promise study","volume":"24","author":"Duong","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"S2","key":"10.1016\/j.jcf.2026.03.024_bib0025","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1016\/S1569-1993(25)02191-5","article-title":"A multi-center study of non-invasive colorectal cancer evaluation in cystic fibrosis (NICE-CF)","volume":"24","author":"Hachem","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.024_bib0026","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2017.10.036","article-title":"Cost effectiveness of screening individuals with cystic fibrosis for colorectal cancer","volume":"154","author":"Gini","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.024_bib0027","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jcf.2018.11.005","article-title":"Cystic fibrosis is associated with an increased risk of Barrett\u2019s esophagus","volume":"18","author":"Knotts","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.03.024_bib0028","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(20)31099-0","article-title":"Cytosponge-trefoil factor 3 versus usual care to identify Barrett\u2019s oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial","volume":"396","author":"Fitzgerald","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2026.03.024_bib0029","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.14309\/ajg.0000000000003238","article-title":"Use of a two-gene methylated DNA biomarker assay and nonendoscopic balloon for detection of Barrett esophagus among high-risk individuals in a screening population","volume":"120","author":"Shaheen","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.024_bib0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jcf.2013.01.004","article-title":"Prevalence of Helicobacter pylori infection in patients with cystic fibrosis","volume":"12","author":"Drzyma\u0142a-Czy\u017c","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.03.024_bib0031","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.14309\/ajg.0000000000002968","article-title":"ACG clinical guideline: treatment of Helicobacter pylori infection","volume":"119","author":"Chey","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcf.2026.03.024_bib0032","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.024_bib0033","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.gie.2021.12.001","article-title":"ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations","volume":"95","author":"Sawhney","year":"2022","journal-title":"Gastrointest Endosc"},{"issue":"9","key":"10.1016\/j.jcf.2026.03.024_bib0034","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJMra2309041","article-title":"Pancreatic Cysts","volume":"391","author":"Gonda","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.024_bib0035","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/HEP.0000000000000646","article-title":"Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations","volume":"79","author":"Sellers","year":"2024","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.024_bib0036","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ajcnut.2025.01.014","article-title":"Dietary-lifestyle patterns and colorectal cancer risk: global cancer update programme (CUP Global) systematic literature review","volume":"121","author":"Chu","year":"2025","journal-title":"Am J Clin Nutr"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:46:09Z","timestamp":1781883969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326000925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1569199326000925"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.03.024","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased gastrointestinal cancer risk in cystic fibrosis: Screening, prevention, and future directions","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}